期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
A novel approach to Parkinson's disease treatment with a potentially dual-acting therapeutic agent that targetsα-synuclein aggregation and neuron death 被引量:1
1
作者 Allison RBalaj hiroaki kaku 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第12期2577-2578,共2页
Parkinson's disease(PD),a prevalent neurodegenerative disorder,is chara cterized by the loss of dopaminergic neurons and the aggregation ofα-synuclein protein into Lewy bodies.While the current standards of thera... Parkinson's disease(PD),a prevalent neurodegenerative disorder,is chara cterized by the loss of dopaminergic neurons and the aggregation ofα-synuclein protein into Lewy bodies.While the current standards of therapy have been successful in providing some symptom relief,they fail to address the underlying pathophysiology of PD and as a result,they have no effect on disease progression. 展开更多
关键词 AGGREGATION DEATH THERAPEUTIC
下载PDF
Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer's disease 被引量:1
2
作者 Allison RBalaj hiroaki kaku 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第12期2677-2679,共3页
Introduction of Fas apoptosis inhibitory molecule(FAIM): FAIM was originally discovered in FASresistant mouse primary B lymphocytes in 1999, and was thought of as a FAS-apoptosis inhibitor based on overexpression stud... Introduction of Fas apoptosis inhibitory molecule(FAIM): FAIM was originally discovered in FASresistant mouse primary B lymphocytes in 1999, and was thought of as a FAS-apoptosis inhibitor based on overexpression studies(Schneider et al., 1999). FAIM is an approximately 20 k Da intracellular protein, but a subsequent study identified an alternatively spliced form. 展开更多
关键词 al. ALZHEIMER LYMPHOCYTES
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部